A Closer Look: China’s Pharmaceutical Bribery Scandal Continues To Spread
This article was originally published in PharmAsia News
Executive Summary
Sanofi is the latest company to feel the heat after an anonymous whistleblower alleged that Chinese employees bribed doctors to prescribe Avapro and Avalide. PharmAsia News takes a closer look at the latest developments in a fast-moving scandal that has engulfed GSK and now threatens others.